EU Panel Votes to Expand Dulaglutide Indication Based on REWIND

http://www.medscape.com/viewarticle/918808?src=rss

The panel also recommends approval of Qtrilmet, a fixed-dose combination of metformin hydrochloride/saxagliptin/dapagliflozin for treatment of type 2 diabetes.
International Approvals

Ryan
Ryan

No Comments

Write a Reply or Comment